All News #Library
Biotech
Neurophth Announces First Patient Dosed in Ph I/II Trial of Second Gene Therapy
17 Aug 2023 //
PR NEWSWIRE
Neurophth Secures $95M in Series C+ Financing for Clinical Trials
14 Aug 2023 //
CONTRACT PHARMA
Neurophth Completes Enrollment for PIII trial for gene therapy treatment of LHON
21 Feb 2023 //
PR NEWSWIRE

Market Place
Sourcing Support